MBC-11
Catalog No. A20015
MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC). Has potential to treat tumor-induced bone disease (TIBD).
Catalog Num | A20015 |
---|---|
M. Wt | 511.21 |
Formula | C11H20N3O14P3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 332863-86-2 |
Synonyms | MBC11, MBC 11 |
SMILES | CC(P(O)(O)=O)(P(O)(OP(O)(OC[C@@H]1[C@@H](O)[C@H](O)[C@H](N2C=CC(N)=NC2=O)O1)=O)=O)O |
MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC). Has potential to treat tumor-induced bone disease (TIBD).
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.56 mL | 97.81 mL | 195.61 mL |
0.5 mM | 3.91 mL | 19.56 mL | 39.12 mL |
1 mM | 1.96 mL | 9.78 mL | 19.56 mL |
5 mM | 0.39 mL | 1.96 mL | 3.91 mL |
*The above data is based on the productmolecular weight 511.21. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.